On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
2016 · Nature · 448 citations
https://doi.org/10.1038/nature19795
A
Abhishek A. Chakraborty
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
2.9K
Citations
20
h-index
28
i10-index
Abhishek A. Chakraborty is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Renal and related cancers & Microtubule and mitosis dynamics. The author has an h-index of 20, co-authored 98 publications.
ORCID: 0000-0002-3382-188XPapers by this author
worksGAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
2023 · Nature Cancer · 193 citations
https://doi.org/10.1038/s43018-023-00556-5
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
2019 · Genes & Development · 124 citations
https://doi.org/10.1101/gad.328336.119
VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms
2024 · Cell Reports · 38 citations
https://doi.org/10.1016/j.celrep.2023.113661
Chronic hypoxia stabilizes 3βHSD1 via autophagy suppression
2024 · Cell Reports · 9 citations
https://doi.org/10.1016/j.celrep.2023.113575
Inspiring Student Entrepreneurship and Innovation
2024 · Cureus · 1 citations
https://doi.org/10.7759/cureus.71195
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat